ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year

February 21, 1986

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

November 28, 2014

In Brief: Hawkins Gets Seat Back On Labor & Human Resources, Loses Subcommittee; Foundation Offers Fellowships

February 11, 1983

Cancer Research Isn’t A Priority In Bush Budget, AACR President Says.

February 9, 2007

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

NCI CTEP-Approved Trials For the Month of August

August 29, 2014